Molecular Diagnostics
Liquid Biopsy Can Detect Recurrent Breast Cancer and Monitor Progression
A new study has found that liquid biopsy performed on serum samples taken from breast cancer patients can provide increasingly accurate information on cancer progression and enable earlier detection of cancer recurrence. More...31 Mar 2022
Thermo Fisher Launches CE-IVD Marked NGS Instrument for Diagnostic Testing
Thermo Fisher Scientific (Waltham, MA, USA) has launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in as little as a single day. Designed for use in clinical laboratories, the fully validated system enables users to perform both diagnostic testing and clinical research on a single instrument. More...31 Mar 2022
Siemens sNfL Blood Test Predicts Risk of MS Disease Activity
The ADVIA Centaur serum Neurofilament Light Chain (sNfL) assay, developed by Siemens Healthineers (Erlangen, Germany) in collaboration with Novartis Pharma AG (Basel, Switzerland), quantitatively measures NfL in human serum and plasma. It is intended to be used in conjunction with clinical, imaging, and laboratory findings as an aid in identifying adult patients with Relapsing Multiple Sclerosis who are at lower risk versus higher risk of MS disease activity. More...31 Mar 2022
Rapid Test Predicts Sepsis Soon After Infection and Before Organ Damage
In a potential paradigm change for sepsis diagnostics, a new test predicted sepsis soon after infection in mice - well before blood clotting and organ failure - enabling early antibiotic treatment and markedly increased survival. More...30 Mar 2022
NGS Panels Detect RNA and DNA Cancer Biomarkers in Single Assay
Vela Diagnostics (Singapore) has launched its new OncoKey SL 60 and 525 Plus Panels. These next-generation sequencing (NGS)-based panels are intended for detection of DNA and RNA cancer biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue specimens, for up to 64 samples in a single sequencing run. More...30 Mar 2022
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
Cooling Table Centrifuge
MPW-352R
New
Vedolizumab ELISA
RIDASCREEN VDZ Monitoring
In Other News
Novel System to Accelerate Development of New Diagnostic Tests
Urine Liquid Biopsy Test Detects Molecular Evidence of Prostate Cancer
BDNF Risk Variant Linked to Brain Inflammation in RRMS Patients
Blood Levels of Glial Fibrillary Acidic Protein Predict Dementia Risk in Older Mexican Americans
A Minimally Invasive PCR Test for Diagnosis of Oral Cancer
Enzyme-Based Point-of-Care Test Could Rapidly Identify Stroke Patients upon Arrival at Hospital
New Antibody Test Diagnoses Multiple Sclerosis in 20 Minutes
An Extracellular Vesicle-based Liquid Biopsy for Early Cancer Detection
Cerebrospinal Fluid Liquid Biopsy for Diagnosis of Metastatic Breast Cancer
Novel Painless Test Massively Simplifies Diagnosis of Allergies and Predicts Success of Immunotherapy
Genetic Overlap Found for Ovarian Cancer Subtypes and Endometriosis
Personalized Tumor-Informed Assay Helps Patients Get Ahead of Cancer
Worm-on-a-Chip Device Could Noninvasively Diagnose Early-Stage Cancer
Pediatric Cancer Sequencing Expands Relapse Treatment Options
Alpha-Synuclein Skin Deposits Characterize Parkinson’s Disease Patients
Blood Plasma Biomarkers Could Improve Diagnostic Tests for Alzheimer's Disease
Groundbreaking DNA Test Evaluates Biomarkers in 517 Cancer-Relevant Genes across 30 Types of Solid Tumors
Single Cell Characterization Acral Melanoma Identifies Novel Targets for Immunotherapy
New Test Could Help Diagnose Lyme Disease Sooner and Determine Treatment Efficacy
Expression, Microbiome Features Provide Pre-Treatment Lung Function Clues for Pediatric Patients
Next-Gen Graphene Biosensor Technology Enables Lab Quality Diagnostics of Infectious Diseases, Anytime, Anywhere
Two Circulating Biomarkers Predict Cardiovascular Disease Risk in Psoriasis Patients
Fecal Microbiome Signature Predicts Pancreatic Cancer Risk
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
